• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日尔共和国实现新冠病毒群体免疫之路:挑战与建议

Road to achieving COVID-19 herd immunity in Niger Republic: Challenges and recommendations.

作者信息

Abdou Sil-Ana Salissou, Amos Oladunni Abimbola, Onwuemene Ogechi Vida, Odey Goodness Ogeyi, Nsikak Abasi Caleb James

机构信息

Faculty of Health Sciences, department of Nursing and midwifery Aboubacar Ibrahim International University Maradi Maradi Niger Republic.

Department of Pharmacology and Therapeutics College of Medicine University of Ibadan, Ibadan, Oyo state Nigeria.

出版信息

Public Health Chall. 2022 Dec;1(4):e38. doi: 10.1002/puh2.38. Epub 2022 Dec 7.

DOI:10.1002/puh2.38
PMID:37519310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9877972/
Abstract

COVID-19 pandemic has had tremendous impact on countries across the world and Niger Republic is not left out of the ravaging impact of the virus. The rapid dissemination of the virus across the globe has led to the development of safe and efficacious vaccines at an unprecedented level. While Niger Republic has prioritized COVID-19 vaccination in line with the global plan to attain herd immunity by vaccinating 70% of world's population, the country has continued to struggle to expand coverage of its population. Niger Republic is faced with challenges such as conflict, COVID-19 vaccine hesitancy, poor COVID-19 vaccine demand and inefficient information system, consequently leading to low COVID-19 vaccine demand and uptake. These challenges coupled with the different wave of the pandemic, the latest largely driven by the Omicron variant has slowed down progress towards achieving herd immunity in Niger Republic. There is need for the Nigerien government to scale up vaccination drive as well as implement refined approaches towards achieving the country's herd immunity target. This paper aimed to discuss the current state of COVID-19 vaccination including efforts and challenges towards achieving herd immunity in Niger Republic, thus informing strategies to ramp up COVID-19 vaccination in the country.

摘要

新冠疫情对世界各国都产生了巨大影响,尼日尔共和国也未能免受该病毒的肆虐影响。病毒在全球的迅速传播促使人们以前所未有的速度研发出安全有效的疫苗。虽然尼日尔共和国按照通过为全球70%的人口接种疫苗以实现群体免疫的全球计划,将新冠疫苗接种列为优先事项,但该国在扩大人口接种覆盖范围方面仍面临困难。尼日尔共和国面临着冲突、对新冠疫苗的犹豫态度、新冠疫苗需求低迷以及信息系统效率低下等挑战,导致新冠疫苗的需求和接种率较低。这些挑战再加上疫情的不同波次,最近主要由奥密克戎变种驱动,减缓了尼日尔共和国实现群体免疫的进程。尼日尔政府需要加大疫苗接种力度,并采取改进措施以实现该国的群体免疫目标。本文旨在讨论新冠疫苗接种的现状,包括在尼日尔共和国实现群体免疫所做的努力和面临的挑战,从而为该国加强新冠疫苗接种的策略提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a83/12039623/2b19ced7692a/PUH2-1-e38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a83/12039623/5fc194273136/PUH2-1-e38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a83/12039623/2b19ced7692a/PUH2-1-e38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a83/12039623/5fc194273136/PUH2-1-e38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a83/12039623/2b19ced7692a/PUH2-1-e38-g001.jpg

相似文献

1
Road to achieving COVID-19 herd immunity in Niger Republic: Challenges and recommendations.尼日尔共和国实现新冠病毒群体免疫之路:挑战与建议
Public Health Chall. 2022 Dec;1(4):e38. doi: 10.1002/puh2.38. Epub 2022 Dec 7.
2
Herd immunity: challenges and the way forward in Korea.群体免疫:韩国面临的挑战与前进道路。
Epidemiol Health. 2021;43:e2021054. doi: 10.4178/epih.e2021054. Epub 2021 Aug 18.
3
COVID-19 and its impacts: The situation in Niger republic.新冠肺炎及其影响:尼日尔共和国的情况
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100797. doi: 10.1016/j.cegh.2021.100797. Epub 2021 May 29.
4
Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.对疫苗类型和免疫对 COVID-19 负担影响的批判性评估。
Math Biosci. 2023 Jun;360:108981. doi: 10.1016/j.mbs.2023.108981. Epub 2023 Feb 16.
5
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.津巴布韦的 SARS-CoV-2:迈向预期 60%群体免疫所面临的里程碑和挑战。
Pan Afr Med J. 2021 Aug 20;39:255. doi: 10.11604/pamj.2021.39.255.30331. eCollection 2021.
6
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
7
Protecting the Herd: Why Pharmacists Matter in Mass Vaccination.保护群体:为何药剂师在大规模疫苗接种中至关重要。
Pharmacy (Basel). 2020 Oct 26;8(4):199. doi: 10.3390/pharmacy8040199.
8
Achieving herd immunity in South America.在南美洲实现群体免疫。
Glob Health Res Policy. 2023 Feb 1;8(1):2. doi: 10.1186/s41256-023-00286-2.
9
COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.法国具有代表性的工作年龄人群中对新冠疫苗的犹豫态度:一项基于疫苗特性的调查实验
Lancet Public Health. 2021 Apr;6(4):e210-e221. doi: 10.1016/S2468-2667(21)00012-8. Epub 2021 Feb 6.
10
Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.实现美国 COVID-19 疫苗衍生群体免疫阈值
Front Public Health. 2021 Jul 23;9:709369. doi: 10.3389/fpubh.2021.709369. eCollection 2021.

引用本文的文献

1
Attitudes towards COVID-19 vaccination: A cross sectional study in the Federal Capital Territory, Nigeria.对新冠病毒疫苗接种的态度:尼日利亚联邦首都地区的一项横断面研究。
PLOS Glob Public Health. 2024 Apr 18;4(4):e0002589. doi: 10.1371/journal.pgph.0002589. eCollection 2024.

本文引用的文献

1
Community-based surveillance contribution to the response of COVID-19 in Niger.社区监测对尼日尔 COVID-19 应对工作的贡献。
Pan Afr Med J. 2021 Oct 11;40:88. doi: 10.11604/pamj.2021.40.88.28175. eCollection 2021.
2
Can Africa achieve herd immunity?非洲能否实现群体免疫?
Glob Health Res Policy. 2021 Dec 2;6(1):46. doi: 10.1186/s41256-021-00231-1.
3
COVID-19 and its impacts: The situation in Niger republic.新冠肺炎及其影响:尼日尔共和国的情况
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100797. doi: 10.1016/j.cegh.2021.100797. Epub 2021 May 29.
4
[COVID-19 control in Niger: an assessment of infection prevention and control practices at healthcare facilities in the city of Niamey].[尼日尔的新冠肺炎防控:尼亚美市医疗机构感染预防与控制措施评估]
Pan Afr Med J. 2020 Nov 11;37(Suppl 1):35. doi: 10.11604/pamj.supp.2020.37.35.26512. eCollection 2020.
5
Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study.绘制全球疫苗信心趋势图并调查疫苗接种障碍:一项大规模回顾性时间建模研究。
Lancet. 2020 Sep 26;396(10255):898-908. doi: 10.1016/S0140-6736(20)31558-0. Epub 2020 Sep 10.
6
Impact of COVID-19 on access to healthcare in low- and middle-income countries: Current evidence and future recommendations.**新冠疫情对中低收入国家医疗卫生服务可及性的影响:现有证据与未来建议**。
Int J Health Plann Manage. 2021 Jan;36(1):13-17. doi: 10.1002/hpm.3067. Epub 2020 Aug 28.